BR100 Increased By (1.26%)
BR30 Increased By (1.3%)
KSE100 Increased By (1.12%)
KSE30 Increased By (1.15%)
AGHA 7.87 Increased By ▲ 0.12 (1.55%)
BECO 5.22 Increased By ▲ 0.03 (0.58%)
BML 59.88 Increased By ▲ 1.22 (2.08%)
BOP 34.42 Increased By ▲ 0.73 (2.17%)
CNERGY 10.95 Increased By ▲ 0.34 (3.2%)
CSIL 5.44 Increased By ▲ 0.14 (2.64%)
FCCL 54.34 Increased By ▲ 0.60 (1.12%)
FFL 16.88 Increased By ▲ 0.42 (2.55%)
FNEL 1.23 Increased By ▲ 0.01 (0.82%)
KEL 7.44 Increased By ▲ 0.16 (2.2%)
KOSM 5.70 Increased By ▲ 0.06 (1.06%)
LOTCHEM 30.07 Increased By ▲ 0.42 (1.42%)
MLCF 97.00 Increased By ▲ 0.64 (0.66%)
NBP 206.00 Increased By ▲ 2.47 (1.21%)
NCPL 57.62 Increased By ▲ 0.77 (1.35%)
NPL 68.74 Increased By ▲ 1.43 (2.12%)
OGDC 321.40 Increased By ▲ 3.18 (1%)
PACE 10.70 Increased By ▲ 0.07 (0.66%)
PAEL 42.52 Increased By ▲ 0.75 (1.8%)
PIBTL 17.00 Increased By ▲ 0.19 (1.13%)
PPL 223.30 Increased By ▲ 3.13 (1.42%)
PRL 52.80 Increased By ▲ 3.75 (7.65%)
PTC 70.72 Increased By ▲ 0.71 (1.01%)
SSGC 29.53 Increased By ▲ 0.39 (1.34%)
TBL 9.93 Increased By ▲ 0.16 (1.64%)
TELE 8.94 Increased By ▲ 0.12 (1.36%)
TPL 17.25 Increased By ▲ 0.08 (0.47%)
TPLP 12.80 Increased By ▲ 0.29 (2.32%)
TREET 22.90 Increased By ▲ 0.31 (1.37%)
TRG 60.86 Increased By ▲ 0.64 (1.06%)
Business & Finance

GSK Pakistan appoints chairperson

Published Updated

Pharmaceutical giant GlaxoSmithKline Pakistan Limited announced on Tuesday the appointment of Dmytro Oliinyk, VP Head of Finance, International Region of GlaxoSmithKline, as Non-Executive Director and Chairperson.

The company disclosed in a notice to the Pakistan Stock Exchange (PSX) today.

It said that Dmytro will fill in the casual vacancy due to the resignation of Lai Kuen Goh from the Board of Directors of GlaxoSmithKline Pakistan Limited.

GlaxoSmithKline Pakistan Limited was incorporated in Pakistan as a limited liability company and is engaged in the manufacturing and marketing of research-based ethical specialities and pharmaceutical products.

The company is a subsidiary of S.R. One International B.V., incorporated in the Netherlands, whereas its ultimate parent company is GlaxoSmithKline plc, UK (GSK plc)

Comments

200 characters remaining